On Thursday, Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial demonstrated that the addition of IBRANCE (palbociclib) to ...

The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the peer-reviewed publication of real-world evidence (RWE) demonstrating that first-line therapy with IBRANCE® (palbociclib) in ...

PFE's oncology results should reflect steady growth from Seagen ADCs and key brands, offset by pricing and competitive ...

CNN reports the increase is up from 250 last year, but the median is around 4% which is in line with 2025. CNN also reports that drugmakers do plan to cut prices on around nine drugs. Prices for at ...

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus on ...

Despite Trump pressure, Big Pharma is raising hundreds of drug prices - Costs of at least 350 branded medications, including vaccines against Covid-19, shingles and cancer treatment Ibrance, will repo ...

NEW YORK – Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID-19, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump ...